Innovative bioprocessing technologies are needed to make monoclonal antibody (mAb) production cheaper, according to new research, which suggests lowering the cost of goods (COGs) for mAb-based ...

ROCKVILLE, Md., March 07, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents ...

The Mortgage Advice Bureau has set out ambitious growth targets as it looks to double its revenue. In an update this morning (February 4), MAB sets out its medium-term growth targets to double ...

These include not only the inherent benefits of full stack observability to help customers anticipate and resolve issues in ...

I-Mab’s pipeline pivot had a sting in the tail. Weeks after shifting its focus, the biotech said Wednesday that it has reduced its workforce by around 27% in conjunction with the pipeline ...

in a spectacular event held at Hangar 6 of the MAB Engineering Complex. The event was officiated by Prime Minister Anwar Ibrahim who unveiled the campaign’s logo, mascot, theme song ...

I-Mab has begun the new year with a pipeline pivot, pausing work on an asset Sanofi bought into last year to focus on its play for the congested CLDN18.2 space. Uliledlimab is the asset I-Mab has ...

Failing to maintain the MAB can lead to penalties, which could range from monthly maintenance fees to, in some cases, account closure. (Image: Freepik) The Monthly Average Balance (MAB ...

ROCKVILLE, Md., June 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of ...

The three organisations, which Gove accused of having an "Islamist orientation", are the Muslim Association of Britain (MAB), Cage International, and Mend. Gove said: "Organisations such as the ...

Feb 7 (Reuters) - I-Mab (IMAB.O), opens new tab said on Wednesday it has agreed to divest its operations and assets in China as part of its strategy to become a U.S.-focused biotech firm ...